Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Review

    An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia

    Sutthaya Poolperm1, Wannee Jiraungkoorskul2 Corresponding author

    1. 1Mahidol University International College, Mahidol University, Nakhon Pathom 73170, THAILAND.
    2. 2Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok 10400, THAILAND.

    CORRESPONDENCE

    Wannee Jiraungkoorskul

    Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok 10400, THAILAND.

    pathobiologymu@gmail.com

    Volume 11, Issue 21 · pp. 31–34 · PUBLISHED · DOI: 10.4103/phrev.phrev_52_16

    View on Pharmacogn. Rev. original site ↗

    ABSTRACT

    Momordica charantia (Family: Cucurbitales), as known as bitter melon or gourd, is a daily consumption as food and traditional medicinal plant in Southeast Asia and Indo‑China. It has been shown to possess anticancer, antidepressant, antidiabetic, anti‑inflammatory, antimicrobial, antiobesity, antioxidant, and antiulcer properties. Its common phytochemical components include alkaloids, charantin, flavonoids, glycosides, phenolics, tannins, and terpenoids. This plant is rich in various saponins including momordicin, momordin, momordicoside, karavilagenin, karaviloside, and kuguacin, all of which have been reported to contribute to its remedial properties including antibacterial, antifungal, antiviral, and antiparasitic infections. Based on established literature on the anthelmintic activity of M. charantia and possible mode of action, this review article has attempted to compile M. charantia could be further explored for the development of potential anthelmintic drug.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Poolperm, S., & Jiraungkoorskul, W. (). An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia. Pharmacognosy Reviews, 11(21), 31–34. https://doi.org/10.4103/phrev.phrev_52_16